Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Response to Biologics During the First Six Months of Therapy in Biologic-naïve Patients with Psoriasis Predicts Risk of Disease Flares: A Danish Nationwide Study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Epidemiology of Hyperhidrosis in Danish Blood Donors

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Vaccination Granuloma Itch Treated with Capsaicin 8% Patches

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  3. Treatment of Widespread Eosinophilic Cellulitis (Wells' Syndrome) with Benralizumab

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  4. Incidence of Kaposi Sarcoma in Sweden is Decreasing

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Effect of Anti-interleukin-17 Treatment on Haemoglobin A1c Levels

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Vis graf over relationer

Early response to treatment with biologics might be important for the stability of psoriasis and long-term outcome. The aim of this study was therefore to assess whether risk of flares and drug survival are associated with disease activity in the first 6 months of treatment of psoriasis with biologics. Biologic-naïve patients from the Danish nationwide registry, DERMBIO, were grouped based on absolute Psoriasis Area and Severity Index (PASI) during the first 6 months of treatment, as: PASI = 0, PASI > 0-≤2, PASI > 2-≤ 4, and PASI > 4. Among 1,684 patients, 746 achieved PASI= 0, 485 PASI > 0-≤2, 246 PASI > 2-≤4, and 207 PASI > 4. Longer flare-free period and drug survival were observed for patients with lower PASI in the first 6 months of treatment (adjusted hazard ratios for flares (95% confidence interval) with PASI=  0 as reference: PASI > 0-≤2 (1.35 (1.11-1.72]), PASI > 2-≤ 4 (2.32 [1.80-2.99]), and PASI > 4 (2.38 [1.80-3.15])). In conclusion, a low PASI in the first 6 months of treatment with biologics in biologic-naïve patients with psoriasis was associated with a more stable disease course, lower risk of flares, and longer drug survival.

OriginalsprogEngelsk
Artikelnummeradv00357
TidsskriftActa Dermato-Venereologica
Vol/bind101
Udgave nummer1
Sider (fra-til)1-7
Antal sider7
ISSN0001-5555
DOI
StatusUdgivet - 4 jan. 2021

ID: 61760793